https://pharmoniq.com/news/telix-20-abstracts-eanm-prostate-brain-renal-cancer-theranostics PharmoniQ en 2026-10-15T14:32:55.056Z Telix to Present 20 Abstracts at EANM Conference Telix Pharmaceuticals, EANM, theranostics, prostate cancer, radiopharmaceuticals https://pharmoniq.com/news/bms-actinium-225-ryz101-phase-3-endpoint-nets PharmoniQ en 2026-10-15T08:00:24.239Z BMS' Actinium-225 Drug Meets Phase III Endpoint in NETs actinium-225, radiopharmaceuticals, neuroendocrine tumors, Bristol Myers Squibb, RYZ101 https://pharmoniq.com/news/pbm-copay-programs-specialty-pharmacy-risk-transfer PharmoniQ en 2026-10-14T14:10:48.970Z PBM Copay Programs Shift Financial Risk to Specialty Pharmacies PBM, specialty pharmacy, copay programs, pharmacy reimbursement, market consolidation